Adesão ao protocolo Enhanced Recovery After Surgery (ERAS) em cirurgia plástica de reconstrução mamária / Adherence to the Enhanced Recovery After Surgery (ERAS) protocol in breast reconstruction plastic surgery

Introdução: O protocolo Enhanced Recovery After Surgery Society (ERAS) revolucionou os cuidados perioperatórios, aprimorando o manejo intra-hospitalar e melhorando desfechos de pacientes submetidas a cirurgia plástica de reconstrução mamária. O objetivo deste estudo foi avaliar a adesão às recomendações do protocolo ERAS para cirurgia plástica em dois hospitais de referência do Sul do país. Método: Estudo transversal, utilizando banco de dados de prontuários, em dois hospitais do Sul do Brasil, nos anos de 2018 a 2021. A definição das variáveis a serem avaliadas foi baseada no protocolo ERAS mais recente proposto por Temple-Oberle e colaboradores. Os resultados foram analisados por epidemiologia descritiva. Resultados: A taxa média de cumprimento do protocolo ERAS por participante foi de 50,7%. O tempo médio de internação foi de 11 horas e 52 minutos. A quantidade de indicações com forte grau de recomendação atingida mostrou capacidade de diminuir tempo de internação (ρ de Spearman = -0,397) (p<0,001). Conclusão: A adesão a medidas de otimização perioperatória em cirurgia plástica de reconstrução mamária é capaz de reduzir tempo de internação dos pacientes. Entretanto, a taxa média de adesão por paciente ainda é baixa, tornando-se evidente a necessidade de otimizar os cuidados dos pacientes submetidos a esta cirurgia.

Introduction: The Enhanced Recovery After Surgery Society (ERAS) protocol has revolutionized perioperative care, improving in-hospital management and outcomes for patients undergoing breast reconstruction plastic surgery. This study evaluated adherence to the ERAS protocol recommendations for plastic surgery in two reference hospitals in the country's south. Method: Cross-sectional study using a medical record database in two hospitals in southern Brazil from 2018 to 2021. The definition of the variables to be evaluated was based on the most recent ERAS protocol proposed by Temple-Oberle and collaborators. The results were analyzed by descriptive epidemiology. Results: The average rate of compliance with the ERAS protocol per participant was 50.7%. The mean length of stay was 11 hours and 52 minutes. The number of indications with a strong degree of recommendation achieved showed the ability to reduce the length of stay (Spearman ρ = -0.397) (p<0.001). Conclusion: Adherence to perioperative optimization measures in breast reconstruction plastic surgery can reduce patients' hospital stays. However, the average adherence rate per patient is still low, making it evident the need to optimize the care of patients undergoing this surgery.

Incidence of infections associated with the use of invasive devices in an ICU after application of the Improvement Science Method

Objective: To reduce the incidence density of ventilator-associated pneumonia (VAP), central line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI) in the intensive care unit (ICU) using the Improvement Science method. Methods: This was a single-center retrospective cohort study. A collaborative quality improvement team developed and implemented local changes to HAI-related processes and protocols. Pre-intervention, intervention, and post-intervention periods were compared. The study was conducted at the Adult ICU of a hospital in southern Brazil. Variables were analyzed using interrupted time series analysis with segmented linear regression, simple correlation, and hypothesis testing. Results: There was a reduction in the incidence density of all infections. VAP was reduced from 27.2% to 7.2% (p < 0.001), CLABSI from 3.0% to 0.9% (p = 0.017), and CAUTI from 8.3% to 1.8% (p < 0.001). The ICU stay was also reduced from 6.7 to 6 days (p = 0.018). Conclusion: There was an improvement in all the evaluated parameters. Ongoing monitoring of related indicators and adherence to implemented measures are essential to sustain improvements. Applying the Improvement Science methodology can reduce the incidence of HAIs in the ICU.

Analysis of notified drug poisoning among children in Santa Catarina state, 2016-2020.

OBJECTIVE: The aim of this study was to analyze the incidence of drug poisoning in children registered in the Santa Catarina Information and Toxicological Assistance Center between 2016 and 2020. METHODS: This observational epidemiological study, with a historical cohort design, was carried out from reported cases of drug poisoning in children aged 0-12 years. Census sampling was used to collect data. RESULTS: There were 4839 reported cases of drug poisoning among children in the State of Santa Catarina in the surveyed period, with an average annual incidence rate of 6 cases/1000 live births. The median age was 3 years. Most cases of poisoning occurred among girls aged 0-3 years by accidental ingestion of drugs at home. There was a predominance of signs and symptoms affecting the nervous system; only a small portion required hospitalization. Most cases were considered mild poisoning with a favorable outcome. No deaths were recorded. There was a tendency of increasing cases over time, however not significant. There is a predominance of incident cases in the Great West of the state, followed by the Midwest and Serra Catarinense regions. CONCLUSIONS: Drug poisoning in children is predominant in early childhood, mainly caused by accidental ingestion of drugs at home. These findings highlight the importance of preventive and educational measures among family members and caregivers.

A carga de doença por COVID-19 em Florianópolis, Santa Catarina, Brasil, no período de um ano / The burden of disease due to COVID-19 in Florianópolis, Santa Catarina, Brazil, over a one-year period

Resumo A COVID-19 gerou impacto na sociedade com elevados índices de morbidade e mortalidade. A utilização de indicador epidemiológico que estime a carga de doença, agregando em uma medida a mortalidade precoce e os casos não fatais, tem potencial de auxiliar no planejamento de ações adequadas em diferentes níveis de atenção à saúde. O objetivo deste artigo é estimar a carga de doença por COVID-19 em Florianópolis/SC de abril de 2020 a março de 2021. Foi realizado um estudo ecológico com dados de notificação e óbitos por COVID-19 no período de 12 meses. Utilizou-se o indicador de carga denominado Anos de Vida Perdidos Ajustados por Incapacidade (DALY), obtido pela soma dos Anos de Vida Perdidos (YLL) com os Anos Vividos com Incapacidade (YLD). Foram incluídos 78.907 casos de COVID-19 confirmados. Desses, 763 evoluíram a óbito no período estudado. No total, foram estimados 4.496,6 DALYs, taxa de 883,8 DALYs/100.000 habitantes. No sexo masculino, foram 2.693,1 DALYs, taxa de 1.098,0 DALYs/100.000 homens. Em mulheres, foram 1.803,8 DALYs, taxa de 684,4 DALYs/100.000 mulheres. A faixa etária mais acometida em ambos os sexos foi de 60 a 69 anos. Foi alta a carga de COVID-19 na cidade estudada. As maiores taxas foram encontradas no sexo feminino e na faixa-etária de 60-69 anos.

Abstract COVID-19 has had a powerful impact on society with high rates of morbidity and mortality. The use of an epidemiological indicator that estimates the burden of a disease by aggregating early mortality and non-fatal cases in a single measure has the potential to assist in the planning of more appropriate actions at different levels of health care. The scope of this article is to estimate the burden of disease due to COVID-19 in Florianópolis/SC from April 2020 through March 2021. An ecological study was carried out with data from notification and deaths by COVID-19 in the period of 12 months. The burden indicator called Disability-Adjusted Life Years (DALY) was used, obtained by adding the Years of Life Lost (YLL) to the Years of healthy life lost due to disability (YLD). A total of 78,907 confirmed COVID-19 cases were included. Of these, 763 died during the period under study. Overall, 4,496.9 DALYs were estimated, namely a rate of 883.8 DALYs per 100,000 inhabitants. In males, there were 2,693.1 DALYs, a rate of 1,098.0 DALYs per 100,000 males. In women, there were 1,803.8 DALYs, a rate of 684.4 DALYs per100,000 women. The age group most affected in both sexes was 60 to 69 years. The burden of COVID-19 was high in the city studied. The highest rates were in females and in the 60-69 age group.

The burden of disease due to COVID-19 in Florianópolis, Santa Catarina, Brazil, over a one-year period. / A carga de doença por COVID-19 em Florianópolis, Santa Catarina, Brasil, no período de um ano.

COVID-19 has had a powerful impact on society with high rates of morbidity and mortality. The use of an epidemiological indicator that estimates the burden of a disease by aggregating early mortality and non-fatal cases in a single measure has the potential to assist in the planning of more appropriate actions at different levels of health care. The scope of this article is to estimate the burden of disease due to COVID-19 in Florianópolis/SC from April 2020 through March 2021. An ecological study was carried out with data from notification and deaths by COVID-19 in the period of 12 months. The burden indicator called Disability-Adjusted Life Years (DALY) was used, obtained by adding the Years of Life Lost (YLL) to the Years of healthy life lost due to disability (YLD). A total of 78,907 confirmed COVID-19 cases were included. Of these, 763 died during the period under study. Overall, 4,496.9 DALYs were estimated, namely a rate of 883.8 DALYs per 100,000 inhabitants. In males, there were 2,693.1 DALYs, a rate of 1,098.0 DALYs per 100,000 males. In women, there were 1,803.8 DALYs, a rate of 684.4 DALYs per100,000 women. The age group most affected in both sexes was 60 to 69 years. The burden of COVID-19 was high in the city studied. The highest rates were in females and in the 60-69 age group.

A COVID-19 gerou impacto na sociedade com elevados índices de morbidade e mortalidade. A utilização de indicador epidemiológico que estime a carga de doença, agregando em uma medida a mortalidade precoce e os casos não fatais, tem potencial de auxiliar no planejamento de ações adequadas em diferentes níveis de atenção à saúde. O objetivo deste artigo é estimar a carga de doença por COVID-19 em Florianópolis/SC de abril de 2020 a março de 2021. Foi realizado um estudo ecológico com dados de notificação e óbitos por COVID-19 no período de 12 meses. Utilizou-se o indicador de carga denominado Anos de Vida Perdidos Ajustados por Incapacidade (DALY), obtido pela soma dos Anos de Vida Perdidos (YLL) com os Anos Vividos com Incapacidade (YLD). Foram incluídos 78.907 casos de COVID-19 confirmados. Desses, 763 evoluíram a óbito no período estudado. No total, foram estimados 4.496,6 DALYs, taxa de 883,8 DALYs/100.000 habitantes. No sexo masculino, foram 2.693,1 DALYs, taxa de 1.098,0 DALYs/100.000 homens. Em mulheres, foram 1.803,8 DALYs, taxa de 684,4 DALYs/100.000 mulheres. A faixa etária mais acometida em ambos os sexos foi de 60 a 69 anos. Foi alta a carga de COVID-19 na cidade estudada. As maiores taxas foram encontradas no sexo feminino e na faixa-etária de 60-69 anos.

Longitudinal Assessment of Virological Failure and Antiretroviral Drug Resistance among Treatment-naive Subjects Living with HIV.

INTRODUCTION: Human immunodeficiency virus (HIV) infection, the etiological agent of acquired immunodeficiency syndrome (AIDS), is a serious public health issue. Therapeutic measures have been successful in increasing the survival and improving the quality of life. However, some treatment-naive subjects living with HIV present resistance-associated mutations as a result of late diagnosis and/or mutant strain infections. The objective of this study was to identify the virus genotype and assess the antiretroviral resistance profile based on the results of HIV genotyping in treatment-naive subjects living with HIV, after six months of taking antiretroviral therapy. METHODS: This was a prospective cohort study on treatment-naive adults living with HIV attending a specialized outpatient clinic in southern Santa Catarina State, Brazil. The participants were interviewed and had blood samples drawn. The genotypic antiretroviral drug resistance profile was examined in patients with detectable viral loads. RESULTS: 65 treatment-naive subjects living with HIV were recruited for this study. After six months of taking antiretroviral therapy, resistance-associated mutations were observed in 3 (4.6%) subjects living with HIV. CONCLUSION: Subtype C was identified as the circulating subtype in southern Santa Catarina State, and L10V, K103N, A98G, and Y179D were the most common mutations found in treatment-naive subjects.

Adenovirus 36 Coinfection in People Living with HIV and its Impact on Lipohypertrophy.

BACKGROUND: Previous studies have implicated human adenovirus 36 (Adv36) as a potential contributor to overweight and obesity. People living with HIV have an altered body composition compared to healthy individuals. There is still no evidence to confirm the relationship of Adv36 as one of the causes of lipohypertrophy. The main objective of this study was to verify the viral Adv36 infection as a factor associated with the presence of lipohypertrophy in HIV-infected individuals. METHODS: A case-control study on people with HIV treated at a specialized public health service in southern Brazil. Subjects underwent interviews, diagnostic tests, and anthropometry to determine lipodystrophy and its classification. Demographic and clinical data were examined to investigate the presence of Adv36. The cases were participants with lipohypertrophy, and the controls were eutrophic participants. RESULTS: 101 participants were included (38 cases and 63 controls), and the frequency of Adv36 infection was 10.9%. There was a statistically significant association between lipohypertrophy and the female sex (p < 0.001), and a trend for the presence of Adv36 (p = 0.059) and lipohypertrophy. After adjustment for confounders, Adv36 has not considered an independent risk factor for lipohypertrophy. Lower levels of glucose were associated with Adv36 infection. CONCLUSION: There was a significant association between lipohypertrophy and the female sex, and no association with lipohypertrophy and Adv36, perhaps due to the small sample size.

Analysis of notified drug poisoning among children in Santa Catarina state, 2016-2020 / Análise das intoxicações medicamentosas notificadas em crianças no estado de Santa Catarina, 2016-2020

ABSTRACT Objective: The aim of this study was to analyze the incidence of drug poisoning in children registered in the Santa Catarina Information and Toxicological Assistance Center between 2016 and 2020. Methods: This observational epidemiological study, with a historical cohort design, was carried out from reported cases of drug poisoning in children aged 0-12 years. Census sampling was used to collect data. Results: There were 4839 reported cases of drug poisoning among children in the State of Santa Catarina in the surveyed period, with an average annual incidence rate of 6 cases/1000 live births. The median age was 3 years. Most cases of poisoning occurred among girls aged 0-3 years by accidental ingestion of drugs at home. There was a predominance of signs and symptoms affecting the nervous system; only a small portion required hospitalization. Most cases were considered mild poisoning with a favorable outcome. No deaths were recorded. There was a tendency of increasing cases over time, however not significant. There is a predominance of incident cases in the Great West of the state, followed by the Midwest and Serra Catarinense regions. Conclusions: Drug poisoning in children is predominant in early childhood, mainly caused by accidental ingestion of drugs at home. These findings highlight the importance of preventive and educational measures among family members and caregivers.

RESUMO Objetivo: Analisar a incidência das intoxicações medicamentosas em crianças registradas no Centro de Informação e Assistência Toxicológica de Santa Catarina entre os anos de 2016 e 2020. Métodos: Estudo epidemiológico observacional, com delineamento de coorte histórica. Foi realizado com base nos casos notificados de intoxicação por medicamentos em crianças de zero a 12 anos. A amostra foi do tipo censo. Resultados: Foram notificadas 4.839 intoxicações medicamentosas em crianças no Estado de Santa Catarina no período, com taxa de incidência média anual de 6 casos/mil nascidos vivos. A idade apresentou mediana de três anos. A maioria (51,5%) dos casos de intoxicação ocorreu entre meninas, até os três anos de idade, de causa acidental, por exposição oral e no domicílio. Houve predomínio de sinais e sintomas que afetaram o sistema nervoso e apenas uma pequena parcela (6,2%) necessitou de hospitalização. A maioria dos casos (65,6%) foi considerada intoxicação leve com evolução favorável. Nenhum óbito foi registrado. Houve tendência de aumento dos casos ao longo do tempo, porém não significativo. Observa-se predomínio de casos incidentes no Grande Oeste, seguido do Meio-Oeste e Serra Catarinense. Conclusões: As intoxicações medicamentosas em crianças predominam na primeira infância, de forma acidental, sendo o ambiente doméstico o principal local. Esses achados destacam a importância de intensificar medidas preventivas e educativas entre familiares e cuidadores de crianças.

Use of tracking drugs for the search of intra-hospital adverse reactions: a pharmacovigilance study.

OBJECTIVE: To estimate the incidence of potential in-hospital adverse reactions  with the use of alert drugs in a general hospital in southern Brazil. Method: Cross-sectional study, carried out in a hospital in southern Brazil. The  electronic medical records (TASY®) of patients hospitalized between January  and August 2020, who were prescribed one of the drugs earmarked for  tracking adverse drug reactions, were evaluated: the drugs included  flumazenil, fexofenadine hydrochloride, naloxone, promethazine, diphenhydramine and loperamide. RESULTS: A total of 13,476 medical records were reviewed and 204 (1.5%)  were included in the study in which tracker use was indicated in the management of adverse drug reactions. In this study a total of 18 different signs or symptoms were found in medical records, with  pruritus/hyperemia/urticaria being the most reported symptoms (n = 76).  Among the drug classes that caused most adverse drug reactions, opioids were  the most mentioned (n = 44). It should be noted that in 49 medical  records the information on which drug caused the adverse events was not  reported. Regarding the cause of hospitalization of patients who used  creening drugs, cancer was the most frequent (n = 37). CONCLUSIONS: This study indicates that the use of trackers can be a tool to  estimate the occurrence of adverse drug reactions and to establish adverse  events related to the use of medications, which should be reported to the  pharmacovigilance service, with a view to patient safety.

OBJETIVO: Estimar la incidencia de potenciales reacciones adversas intrahospitalarias con el uso de prescripciones alertantes en un  hospital general del sur de Brasil.Método: Estudio transversal, realizado en un hospital del sur de Brasil. Se  evaluaron las historias clínicas electrónicas (TASY®) de los pacientes hospitalizados entre enero y agosto de 2020, a los que se les  prescribió uno de los medicamentos destinados al seguimiento de reacciones  adversas a medicamentos: los medicamentos incluían flumazenil, clorhidrato de fexofenadina, naloxona, prometazina, difenhidramina y  loperamida. RESULTADOS: Se revisaron 13.476 historias clínicas y se incluyeron 204 (1,5%) en el estudio en el que se indicó el uso de prescripciones alertantes en  el manejo de reacciones adversas a medicamentos. En este estudio se  encontró un total de 18 signos o síntomas diferentes en las historias clínicas,  siendo el prurito, la hiperemia y la urticaria los síntomas más reportados (n =  76). Entre las clases de fármacos que causaron la mayoría de las reacciones  adversas a medicamentos, los opioides fueron los más mencionados (n = 44).  Cabe señalar que en 49 historias clínicas no se reportó la información sobre  qué fármaco causó los eventos adversos. En cuanto a la causa de  hospitalización de los pacientes que utilizaron prescripciones alertantes, el  cáncer fue la más frecuente (n = 37). Conclusiones: Este estudio indica que el uso de alertadores puede ser una  herramienta para estimar la incidencia de reacciones adversas a medicamentos y establecer eventos adversos relacionados con el uso de medicamentos, los cuales deben ser reportados al servicio de  armacovigilancia, con miras a la seguridad del paciente.

Prevalence of Potential Pharmacological Interactions in Patients Undergoing Systemic Chemotherapy in a Tertiary Hospital.

Introduction: Pharmacological interactions are frequently observed in patients with chronic diseases, and their occurrence is proportional to the amount of medication used daily. Patients undergoing chemotherapy treatment commonly have comorbidities, which favor a greater prevalence of polypharmacy, increasing the risk of drug interactions. Therefore, the aim of this study was to estimate the prevalence of drug interactions in patients undergoing intravenous chemotherapy treated at a hospital oncology service in southern Brazil. Methods: This was an observational study with a cross-sectional design that was carried out with the analysis of secondary data obtained through the review of medical records. The population assessed consisted of all cancer patients who received intravenous chemotherapy from October to December 2020. Results: Out of the 297 patients included in the study, 231 (77.8%) had at least 1 potential pharmacological interaction. In total, 1044 drug interactions were found that were classified according to severity, resulting in 18 (1.7%) contraindicated drug-drug interactions (DDI), 699 (67%) severe, 281 (26.9%) moderate, and 46 (4.4%) minor interactions. There was an association between polypharmacy and the prevalence of drug interactions. Conclusion: The results demonstrate that a large percentage of patients undergoing chemotherapy are susceptible to drug interactions. Thus, it is necessary that prescribers consider all drugs used by patients and, when possible, prescribe alternative drugs that have less potential for interaction in order to prevent drug interactions adverse effects and provide a better prognosis for patients.

Analysis of the first test event in Santa Catarina, Brazil, in the context of the COVID-19 pandemic in July 2021: an experience report. / Análise do primeiro evento-teste de Santa Catarina no contexto da pandemia da COVID-19, em julho de 2021: um relato de experiência.

This study aimed to describe the management and results of the test event for evaluating relaxation of social distancing measures in Santa Catarina, Brazil. This is an experience report that described results of the test event carried out in July 2021 and for which the participants underwent real-time polymerase chain reaction diagnostic testing 72-48 hours before the event and had follow-up for 15 days afterwards. The outcomes analyzed were SARS-CoV-2 infection up to 14 days after the event and presence of symptoms. Among 313 participants, the mean age was 45.1 years and 54.3% were female. During follow-up, 7.7% (24) of the contacted participants reported symptoms compatible with infection, but of the 240 who attended post-event testing, none of the results detected the presence of the virus. No post-event COVID-19 cases were reported. We suggest that other test events be carried out to evaluate the recommendations indicated.

Este estudo visou descrever a gestão e os resultados do evento-teste para flexibilização das medidas de distanciamento em Santa Catarina, Brasil. Trata-se de relato de experiência que descreveu os resultados do evento-teste, realizado em julho de 2021, quando os participantes foram submetidos ao teste diagnóstico de reação em cadeia da polimerase em tempo real 72-48 horas antes, sendo monitorados por 15 dias. Os desfechos analisados foram a infecção pelo SARS-CoV-2 até 14 dias após o evento e a presença de sintomas. Entre 313 participantes, a média de idade foi de 45,1 anos e 54,3% eram do sexo feminino. No monitoramento, 7,7% (24) dos participantes contactados relataram sintomas compatíveis com infecção, embora, dos 240 que compareceram para testagem pós-evento, nenhum resultado tenha acusado presença do vírus. Não houve registro de casos de COVID-19 pós-evento. Sugere-se realização de outros eventos-teste para avaliar as recomendações indicadas.

Este estudio tuvo como objetivo describir la gestión y los resultados del evento test para flexibilizar las medidas de distanciamiento en Santa Catarina, Brasil. Este es un relato de experiencia que describe los resultados del evento, realizado en julio de 2021 y para el cual, los participantes se sometieron a la prueba diagnóstica de reacción en cadena de la polimerasa en tiempo real, 72-48 horas antes, monitoreados durante 15 días. Los desenlaces analizados fueron la infección por SARS-CoV-2 hasta 14 días después del evento y presencia de síntomas. Entre 313 participantes, la edad promedio fue de 45,1 años y 54,3% fueran del sexo femenino. En el seguimiento, 7,7% (24) reportaron síntomas compatibles con infección, pero de los 240 que acudieron a los exámenes posteriores al evento, ninguno de los resultados detectó virus. No se informaron casos de COVID-19 posteriores al evento. Se sugiere realizar otros eventos de prueba para evaluar las recomendaciones indicadas.

Temporal trend and spatial distribution of cases of mother-to-child transmission of HIV in the state of Santa Catarina, Brazil, 2007-2017: an ecological study. / Tendência temporal e distribuição espacial dos casos de transmissão vertical do HIV em Santa Catarina, 2007-2017: um estudo ecológico.

OBJECTIVE: To analyze the temporal trend and spatial distribution of mother-to-child HIV transmission in Santa Catarina between 2007 and 2017. METHODS: This was a mixed ecological study with data from the Notifiable Health Conditions Information System. Linear regression was performed for time series analysis and the mean rates in the period and mean annual percentage changes in the rates of HIV-infected pregnant women were calculated, children exposed to HIV during pregnancy, and seroconversion of children exposed to HIV/AIDS during pregnancy, in addition to data geoprocessing. RESULTS: There were 5,554 records of HIV-infected pregnant women, with a rate of 5.6 pregnant women per 1,000 live births. The mean seroconversion rate was 13.5/100,000 live births (95%CI 6.8;20.1) and it showed a falling trend (APC = -99.4%; 95%CI -99.9;-93.1). The seroconversion rate was more expressive in small towns. CONCLUSION: The rate of HIV-infected pregnant women was stable in the period, whereas the number of children infected with HIV through mother-to-child transmission decreased.

Risk factors for seroconversion of HIV among children exposed in the State of Santa Catarina, 2007-2017 / Fatores de risco para a soroconversão de crianças expostas ao HIV no Estado de Santa Catarina, 2007-2017

Abstract Objectives: to estimate the proportion of seroconversion cases among infants exposed to HIV and verify the risk factors associated. Methods: this was a historical cohort study conducted in the State of Santa Catarina between 2007 and 2017. The data were obtained from the Notifable Diseases Information System (SINAN - Portuguese acronym) that records HIV-infected pregnant women and HIV-exposed infants. The public health service monitored the infants from birth to 18 months of age to determine whether HIV seroconversion occurred. Results: a total of 5,554 HIV-infected pregnant women were included in the study (mean age 26.7±6.5 years). They were predominantly white, with poor education level, and were diagnosed with HIV until the 2nd trimester of pregnancy. A total of 4,559 records of HIV-exposed infants were screened, of which 130 cases (2.9%) of seroconversion were confrmed. Non-use of antiretroviral drugs during pregnancy (OR=9.31, CI95%=5.97-14.52; p<0.001) and breastfeeding (OR=3.10, CI95%=1.34-7.20; p=0.008) were independent risk factors for seroconversion. Conclusions: these data demonstrate gaps in prenatal care, regarding adherence to treatment and monitoring of HIV-infected mothers, resulting in new cases of HIV among children, which could be avoided.

Resumo Objetivos: estimar a proporção de soroconversão da criança exposta ao HIV e verificar os fatores de risco associados, no período de 2007-2017 em Santa Catarina. Métodos: o delineamento utilizado foi de coorte histórica e os dados obtidos no Sistema de Informação de Agravos de Notificação (SINAN) que registra as gestantes infectadas e as crianças expostas ao HIV. As crianças foram acompanhadas pelo serviço de saúde desde o nascimento até o 18º mês de vida, para determinar a ocorrência de soroconversão pelo HIV. Resultados: foram identificadas 5.554 gestantes infectadas pelo HIV com média de idade de 26,7±6,5 anos, predomínio da raça branca, baixa escolaridade e que receberam o diagnóstico para o HIV até o 2º trimestre gestacional. Foram incluídas 4.559 fichas de crianças expostas ao HIV, das quais 130 casos (2,9%) de soroconversão foram confrmados. O não uso de antirretroviral durante a gestação (OR=9,31, IC95%=5,97-14,52; p<0,001) e aleitamento materno (OR=3,10, IC95%=1,34-7,20; p=0,008) foram fatores de risco independentes para a soroconversão. Conclusões: esses dados demonstram lacunas na assistência pré-natal, quanto a adesão ao tratamento e acompanhamento de mães infectadas pelo HIV, resultando em casos novos de HIV entre crianças, que poderiam ser evitados.

Validation of a computerized decision support system to review pharmacotherapy treatment: scheduling guidelines.

BACKGROUND: The review of pharmacotherapy can be conceptualized as a service in which the drugs used by the patient are reviewed to control the risks as well as to improve the results of the drug therapy, detecting, solving, and preventing issues associated with the drug, readjusting the doses and times (schedule) so that the treatment is not incompatible or in duplicity. METHODS: The aim of the study was to validate an intelligent information system, which was developed to assist the scheduling activity in the pharmacotherapy review. The system used the concept of Genetic Algorithms. To validate the system, hypothetical cases were elaborated considering various aspects of pharmacotherapy such as underdose, overdose, drug interactions and contraindications. These cases were tested in the system and were also analyzed by pharmaceutical experts with clinical and research experience in the pharmacotherapy review process. The degree of agreement between the assessments of the appointments carried out by the pharmaceutical specialists and by the system were measured using the Kappa index with a 95% confidence interval. RESULTS: In detecting errors and make propositions, the system was able to identify 80% of errors, with pharmaceutical experts identifying between 20 and 70% of errors. In relation the results of kappa between the cases, the system had 87,3% of concordance, whereas the best pharmaceutical expert had 75,5% of concordance, considering the correct answer. CONCLUSION: It can be concluded that with the methodology used, the investigation met the objectives and confirmed the system is effective for pharmaceutical review process. There are indications that the system can help in the Pharmacotherapy review process, being able to find prescription errors as well as to establish times for the use of medications according to the patient's routine.

Analysis of the first test-event of Santa Catarina, Brazil, no contexto da COVID-19 pandemic em julho de 2021: experience report / Análisis del primer evento-prueba de Santa Catarina, Brasil, no contexto da pandemia COVID-19 em julho de 2021: informe de experiencia / Análise do primeiro evento-teste de Santa Catarina no contexto da pandemia da COVID-19 em julho de 2021: um relato de experiência

This study aimed to describe the management and results of the test event to make distancing measures more flexible in Santa Catarina, Brazil. This is an experience report that described results of the test-event, carried out in July 2021 and for which the participants underwent the real-time polymerase chain reaction diagnostic test 72-48 hours before, being monitored for 15 days. The outcomes analyzed were SARS-Cov-2 infection up to 14 days after the event and presence of symptoms. Among 313 participants, the mean age was 45.1 years and 54.3% were female. In the monitoring, 7.7% (24) of the contacted participants reported symptoms compatible with infection, but of the 240 who attended for post-event testing, none of the results detected the presence of the virus. There were no post-event COVID-19 cases reported. It is suggested that other test-events be carried out to evaluate the recommendations indicated.

Este estudio tuvo como objetivo describir la gestión y los resultados del evento de prueba para flexibilizar las medidas de distanciamiento en Santa Catarina, Brasil. Este es relato de experiencia que describió resultados del evento, realizado en julio de 2021 y para el cual los participantes se sometieron a la prueba diagnóstica de reacción en cadena de la polimerasa en tiempo real 72-48 horas antes, monitoreados durante 15 días. Los desenlaces analizados fueron infección por SARS-Cov-2 hasta 14 días después del evento y presencia de síntomas. Entre 313 participantes, la edad media fue 45,1 años y 54,3% mujeres. En el seguimiento, 7,7% (24) reportaron síntomas compatibles con infección, pero de los 240 que acudieron a los exámenes posteriores al evento, ninguno de los resultados detectó virus. No se informaron casos posteriores al evento de COVID-19. Se sugiere realizar otros eventos de prueba para evaluar recomendaciones indicadas.

Este estudo visou descrever a gestão e os resultados do evento-teste para flexibilização das medidas de distanciamento em Santa Catarina, Brasil. Trata-se de relato de experiência que descreveu os resultados do evento-teste, realizado em julho de 2021, quando os participantes foram submetidos ao teste diagnóstico de reação em cadeia da polimerase em tempo real 72-48 horas antes, sendo monitorados por 15 dias. Os desfechos analisados foram a infecção pelo SARS-Cov-2 até 14 dias após o evento e a presença de sintomas. Entre 313 participantes, a média de idade foi de 45,1 anos e 54,3% eram do sexo feminino. No monitoramento, 7,7% (24) dos participantes contactados relataram sintomas compatíveis com infecção, embora dos 240 que compareceram para testagem pós-evento, nenhum resultado acusou presença do vírus. Não houve registro de casos de COVID-19 pós-evento. Sugere-se realização de outros eventos-teste para avaliar as recomendações indicadas.

Potential Drug Interactions Between Psychotropics and Intravenous Chemotherapeutics Used by Patients With Cancer.

Introduction: Patients undergoing cancer treatment usually have comorbidities, and psychiatric disorders are commonly seen in these patients. For the treatment of these psychiatric disorders, the use of psychotropic drugs is common, turning these patients susceptible to untoward drug interactions. Therefore, the aim of this study was to estimate the prevalence of clinically relevant drug-drug interactions (DDI) between chemotherapeutic and psychotropic agents in patients with cancer treated at an oncology service in southern Brazil. Methods: An observational epidemiological study with a cross-sectional census-type design was carried out between October and December 2020. The drug-drug interactions were identified through consultation and analysis of the Medscape Drug Interaction Check and Micromedex databases. The interactions were classified as major, when the interaction can be fatal and/or require medical intervention to avoid or minimize serious adverse effects and moderate, when the interaction can exacerbate the patient's condition and/or requires changes in therapy. Results: A total of 74 patients was included in the study among the 194 patients seen in the oncology service during the period studied. A total of 24 (32.4%) DDIs were found, 21 (87.5%) of which were classified as being of major risk and 3 (12.5%) as moderate risk. According to the mechanism of action, 19 (79.1%) were classified as pharmacodynamic interactions and 5 (20.9%) as pharmacokinetic interactions. Conclusion: It was shown that a considerable percentage of patients undergoing intravenous chemotherapy are at risk of pharmacological interaction with psychotropic drugs. Thus, it is essential that the oncologist considers all psychotropic drugs and other drugs used by patients in order to avoid drug-drug interactions.

Temporal trend and spatial distribution of cases of mother-to-child transmission of HIV in the state of Santa Catarina, Brazil, from 2007- 2017: an ecological study / Tendencia temporal y distribución espacial de los casos de transmisión vertical del VIH en el estado de Santa Catarina, Brasil, entre 2007 y 2017: un estudio ecológico / Tendência temporal e distribuição espacial dos casos de transmissão vertical do HIV em Santa Catarina entre 2007 e 2017: um estudo ecológico

Objective: To analyze the temporal trend and spatial distribution of HIV mother-to-children transmission in Santa Catarina, 2007-2017. Methods: Mixed ecological study with data from the Notifiable Diseases Information System. Linear regression was performed for time series analysis and the mean rates in the period and annual mean percentage changes in the rates of HIV-infected pregnant women were calculated; of children exposed to HIV during pregnancy; and seroconversion of children exposed to HIV/AIDS during pregnancy, in addition to data geoprocessing. Results: There were 5,554 pregnant women living with HIV, with a rate of 5.6 pregnant infected. The mean seroconversion rate was 13.5/100,000 live births (95%CI 6.8;20.1) and showed a decreasing trend (APC=-99.4%; 95%CI-99.9;-93.1). The seroconversion rate was more expressive in small towns. Conclusion: The rate of HIV-infected pregnant women was stable in the period, whereas the number of children infected with HIV by vertical transmission decreased.

Objetivo: Estimar la tendencia temporal y distribución de casos de VIH por transmisión vertical en Santa Catarina, 2007-2017. Métodos: Estudio ecológico mixto con datos del Sistema de Información de Enfermedades de Declaración Obligatoria. Se utilizó regresión lineal para análisis de series de tiempo y se calcularon las tasas medias en período y los cambios porcentuales medios anuales en las tasas de mujeres embarazadas infectadas por el VIH; de niños expuestos al VIH; y seroconversión de niños expuestos al VIH/SIDA durante el embarazo, además geoprocesamiento de datos. Resultados: Había 5.554 gestantes infectadas por el VIH, con tasa de 5,6 gestantes/1.000 nacidos vivos. La tasa media de seroconversión fue 13,5/100.000 nacidos vivos (IC95% 6,8;20,1) y mostró tendencia decreciente (APC=-99,4%; IC95%-99,9;-93,1). La tasa de seroconversión fue más expresiva en los municipios pequeños. Conclusión: Hubo una estable tasa de mujeres embarazadas infectadas por el VIH, mientras que el número de niños infectados por el VIH disminuyó.

Objetivo: Analisar a tendência temporal e distribuição espacial dos casos de transmissão vertical do HIV em Santa Catarina, de 2007-2017. Métodos: Estudo ecológico misto com dados do Sistema de Informação de Agravos de Notificação. Realizou-se regressão linear para análise de série temporal e calcularam-se as taxas médias no período e variações percentuais médias anuais das taxas de gestantes infectadas pelo HIV; de crianças expostas ao HIV na gestação; e de soroconversão das crianças expostas ao HIV/aids na gestação, além do geoprocessamento dos dados. Resultados: Foram registradas 5.554 gestantes infectadas com HIV, com taxa de 5,6 gestantes/1.000 nascidos vivos. A taxa média de soroconversão foi de 13,5/100.000 nascidos vivos (IC95% 6,8;20,1) e apresentou tendência decrescente (APC=-99,4%; IC95% -99,9;-93,1). A taxa de soroconversão foi mais elevada em municípios de pequeno porte. Conclusão: A taxa de gestantes infectadas pelo HIV foi estável e houve diminuição de crianças infectadas pelo HIV por via vertical.

Uso de fármacos alertantes para la detecciónde reacciones adversas intrahospitalarias: estudio de farmacovigilancia / Use of tracking drugs for the search of intra-hospital adverse reactions: a pharmacovigilance study

Objetivo: Estimar la incidencia de potenciales reacciones adversasintrahospitalarias con el uso de prescripciones alertantes en un hospitalgeneral del sur de Brasil.Método: Estudio transversal, realizado en un hospital del sur de Brasil.Se evaluaron las historias clínicas electrónicas (TASY®) de los pacienteshospitalizados entre enero y agosto de 2020, a los que se les prescribióuno de los medicamentos destinados al seguimiento de reacciones adversasa medicamentos: los medicamentos incluían flumazenil, clorhidratode fexofenadina, naloxona, prometazina, difenhidramina y loperamida.Resultados: Se revisaron 13.476 historias clínicas y se incluyeron 204 (1,5%)en el estudio en el que se indicó el uso de prescripciones alertantes en elmanejo de reacciones adversas a medicamentos. En este estudio se encontró untotal de 18 signos o síntomas diferentes en las historias clínicas, siendo el prurito,la hiperemia y la urticaria los síntomas más reportados (n = 76). Entre las clasesde fármacos que causaron la mayoría de las reacciones adversas a medicamentos,los opioides fueron los más mencionados (n = 44). Cabe señalar queen 49 historias clínicas no se reportó la información sobre qué fármaco causólos eventos adversos. En cuanto a la causa de hospitalización de los pacientesque utilizaron prescripciones alertantes, el cáncer fue la más frecuente (n = 37). Conclusiones: Este estudio indica que el uso de alertadores puede seruna herramienta para estimar la incidencia de reacciones adversas a medicamentosy establecer eventos adversos relacionados con el uso demedicamentos, los cuales deben ser reportados al servicio de farmacovigilancia,con miras a la seguridad del paciente.

Objective: To estimate the incidence of potential in-hospital adversereactions with the use of alert drugs in a general hospital in southernBrazil.Method: Cross-sectional study, carried out in a hospital in southernBrazil. The electronic medical records (TASY®) of patients hospitalizedbetween January and August 2020, who were prescribed one of thedrugs earmarked for tracking adverse drug reactions, were evaluated:the drugs included flumazenil, fexofenadine hydrochloride, naloxone, promethazine,diphenhydramine and loperamide.Results: A total of 13,476 medical records were reviewed and 204(1.5%) were included in the study in which tracker use was indicated in themanagement of adverse drug reactions. In this study a total of 18 differentsigns or symptoms were found in medical records, with pruritus/hyperemia/urticaria being the most reported symptoms (n = 76). Among the drugclasses that caused most adverse drug reactions, opioids were the mostmentioned (n = 44). It should be noted that in 49 medical records theinformation on which drug caused the adverse events was not reported.Regarding the cause of hospitalization of patients who used screeningdrugs, cancer was the most frequent (n = 37). Conclusions: This study indicates that the use of trackers can be a toolto estimate the occurrence of adverse drug reactions and to establishadverse events related to the use of medications, which should be reportedto the pharmacovigilance service, with a view to patient safety.

Adenovirus 36 infection and obesity risk: current understanding and future therapeutic strategies.

INTRODUCTION: Obesity, a multifactorial disease caused by the interaction between genetic characteristics, metabolism, lifestyle, and environmental factors, is a major global health problem and is currently defined as a pandemic phenomenon. This disease is determined by an interaction of several factors, but the imbalance between energy consumption and expenditure seems to be the crucial point. In some cases, there is no linearity between exposure to those factors that cause the onset of obesity. A striking example of the occurrence of obesity despite no obvious risk factors is that of obesity induced by viral infections. The most important of such viruses appears to be human adenovirus 36 (Adv36). AREAS COVERED: This review covers the relation between obesity and infection by Adv36 in humans. Also, discussed are the opportunities of prevention or treatment for the effects of Adv36 in human body. EXPERT OPINION: The role of Ad36 in the development of obesity has already been established. Future research should focus on the development of vaccines against this agent, drug discovery for infected individuals, and effective therapeutic uses of E4orf1 gene protein for diabetes and other diseases in clinical practice.

Time trend and causes of HIV/AIDS mortality in the state of Santa Catarina, 2010­2019 / Tendência temporal e causas de mortalidade por HIV/AIDS no estado de Santa Catarina, 2010­2019

Introduction: Although the acquired immunodeficiency syndrome (AIDS) has no cure, antiretroviral treatment has considerably increased the survival of people living with the disease or with the human immunodeficiency virus (HIV), reducing the incidence of opportunistic infections in these patients. Thus, this treatment changed mortality rates and diversified the causes of death, including reasons related to increased longevity, such as chronic noncommunicable diseases, common in the uninfected population. Therefore, the current epidemiological transition motivated us to study the death profile of people with HIV/AIDS in the state of Santa Catarina. Objective: To investigate case characteristics, as well as the time trend and distribution of deaths, among people with HIV/AIDS in Santa Catarina between 2010 and 2019. Methods: In this ecological, epidemiological study, we consulted all death records from the Santa Catarina Mortality Information System that had HIV/AIDS among the causes and occurred between 2010 and 2019. Results: A total of 5,174 death records were analyzed. In the period, the mean mortality rate among people with HIV/AIDS was 7.64 deaths per 100 thousand inhabitants (95% confidence interval ­ 95%CI 6.61­8.67) ­ 8.99 in 2010 and 6.06 in 2019 ­, showing a downward trend of 0.38% per year. Conclusion: We identified a downward trend in mortality. Deaths were concentrated on the coast, in more populous cities. Furthermore, the finding of improper completion of the death certificate points to the need to invest in improving the training of professionals responsible for this document.

Introdução: Embora a síndrome da imunodeficiência adquirida (AIDS) não tenha cura, o tratamento antirretroviral aumentou consideravelmente a sobrevida das pessoas que vivem com a doença ou com o vírus da imunodeficiência humana (HIV), diminuindo a ocorrência de infecções oportunistas nesses pacientes. Assim, esse tratamento mudou as taxas de mortalidade e diversificou as causas de óbito, incluindo motivos relacionados ao aumento da longevidade, como doenças crônicas não transmissíveis comuns à população não infectada. Dessa forma, a atual transição epidemiológica motiva o estudo do perfil dos óbitos em pessoas com HIV/AIDS no estado de Santa Catarina. Objetivo: Investigar as características dos casos, a tendência temporal e a distribuição dos óbitos em pessoas com HIV/AIDS no estado de Santa Catarina entre os anos de 2010 e 2019. Métodos: Neste estudo epidemiológico com delineamento ecológico, foram consultados todos os registros de óbitos do Sistema de Informação sobre Mortalidade de Santa Catarina ocorridos entre os anos de 2010 e 2019 que apresentassem entre as causas o HIV/AIDS. Resultados: Foram analisados 5.174 registros de óbitos. A taxa de mortalidade média entre pessoas com HIV/AIDS do período foi de 7,64 óbitos a cada 100 mil habitantes (95% intervalo de confiança ­ IC95% 6,61­8,67), sendo de 8,99 em 2010 e 6,06 em 2019, mostrando tendência de queda de 0,38 pontos percentuais ao ano. Conclusão: Observou-se tendência de queda na mortalidade. A concentração dos óbitos foi na faixa litorânea, em cidades mais populosas. Ademais, a constatação do falho preenchimento da declaração de óbito aponta para a necessidade de investir no aprimoramento do treinamento dos profissionais responsáveis por esse documento.